Literature DB >> 8622507

Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition.

S H Murch1, P J Winyard, S Koletzko, B Wehner, H A Cheema, R A Risdon, A D Phillips, N Meadows, N J Klein, J A Walker-Smith.   

Abstract

BACKGROUND: The molecular basis of protein-losing enteropathy is unknown. However it has been shown that sulphated glycosaminoglycans may be important in regulating vascular and renal albumin loss.
METHODS: We describe three baby boys who presented within the first weeks of life with massive enteric protein loss, secretory diarrhoea, and intolerance of enteral feeds. All required total parenteral nutrition and repeated albumin infusions. No cause could be found in any case despite extensive investigations, including small intestinal biopsy sampling, which were repeatedly normal.
FINDINGS: By specific histochemistry, we detected gross abnormality in the distribution of small intestinal glycosaminoglycans in all three infants, with complete absence of enterocyte heparan sulphate. The distribution of vascular and lamina propria glycosaminoglycans was, however, normal.
INTERPRETATION: The presentation of these infants suggests that enterocyte heparan sulphate is important in normal small intestinal function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622507     DOI: 10.1016/s0140-6736(96)90941-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation.

Authors:  V Westphal; S Murch; S Kim; G Srikrishna; B Winchester; R Day; H H Freeze
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 2.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion.

Authors:  Andrew A O Fagbemi; Franco Torrente; Andrew J W Hilson; Michael A Thomson; Robert B Heuschkel; Simon H Murch
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

Review 4.  Medical management of the failing Fontan.

Authors:  N S Ghanayem; S Berger; J S Tweddell
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

5.  Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.

Authors:  Lars Bode; Camilla Salvestrini; Pyong Woo Park; Jin-Ping Li; Jeffrey D Esko; Yu Yamaguchi; Simon Murch; Hudson H Freeze
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 6.  Clinical Approaches to the Patient with a Failing Fontan Procedure.

Authors:  Robert W Elder; Fred M Wu
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

Review 7.  Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Interdiscip Toxicol       Date:  2013-12

8.  Two-Photon Macromolecular Probe Based on a Quadrupolar Anthracenyl Scaffold for Sensitive Recognition of Serum Proteins under Simulated Physiological Conditions.

Authors:  Marco Deiana; Bastien Mettra; Leszek M Mazur; Chantal Andraud; Marek Samoc; Cyrille Monnereau; Katarzyna Matczyszyn
Journal:  ACS Omega       Date:  2017-09-12

Review 9.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

Review 10.  Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2017-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.